Bioheart said it has received a patent for a method to repair damaged heart tissue by a combination of cell transplantation and electrostimulation. The Sunrise-based biotech, which went public in February, said one potential application for the patented technology is to adapt a bi-ventricular pacemaker with a separate lead that could apply the electrostimulation to the cell-transplanted regions. The technology may also be to combined with Bioheart’s MyoCell therapy for the recovery of heart muscle in cardiac patients afflicted with damaged heart tissue.
Please click on the link below to read the South Florida Business Journal article:
http://www.bizjournals.com/southflorida/stories/2008/03/17/daily13.html?f=et81&ana=e_du
For more information on defending medical malpractice, nursing home and general liability matters in Florida contact Howard Citron at Citron & Associates, P.A. – www.citronlegal.com.
